SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : SCOTTS LIQUID GOLD - NYSE sym SGD - Beats OPTIONS! -- Ignore unavailable to you. Want to Upgrade?


To: ChinuSFO who wrote (215)4/26/1999 3:05:00 PM
From: J R KARY  Respond to of 222
 
Hope to analyze the 10 Q , SGD needs to revitalize the A-H marketing

Expect to see a lot of new (3) skin-care product start-up expense and of course , if it were $50 mln in '98 revs the expenses would be less of a factor .

New products add cost without revenue but SGD states it knows how to maximize its maturing A-H (Alpha Hydrox) products profitability .

SGD knows it requires emphasizing your product's benefits clearly over your "on shelf" competitor's as the target who is now a "in store" buyer .

Clearly put buying "power words" on the Red Box , add side bar colors to separate the red boxes from shelf blending , reduce seasonality by suggesting "summer" use etc and unify or simplify the A-H product line.

Shelf space is priceless . SGD has achieved good spots in most stores and a revitalized A-H line could be very profitable .

As investors with a long term horizon we shouldn't give up on this little doggie and as we are near bottom . Timing SGD's bad news for Friday's close was a blessing.

1998 was a costly year due to SGD's Family lawsuit and the Annual Report's tribute to the late Mrs Goldstein signals its closure .

SGD needs 1999 to connect the (marketing) dots.

Jim K.

PS: CR , Thanks for the HS lead - looking into it .



To: ChinuSFO who wrote (215)4/28/1999 1:21:00 PM
From: J R KARY  Read Replies (1) | Respond to of 222
 
Heavy trading today >75k SGD shrs - maybe 10 Q filed ?

Are we going to see some bad sales news in the 10 Q ?

If the guess is right its the start up expense weighed against a A-H sales decline not bouyed by the new product (Res Q) "fill out" .

The Alpha Hydrox (A-H) product line revenue decline is mischaracterized as "mature" and mainly suffers from stale advertising with its packaging lacking motivation to buy .

It's (A - H) a "brand" product bought by "regulars" who know its value in spite of this . Hope SGD moves rapidly to improve the situation .

On today's trading - Wouldn't it be nice if we could time the sellers ? Hope its impatient shareholders taking a SGD loss against their other profitable holdings .

Shareholder's meeting less than 2 weeks away !

Jim K.

PS: Great heads up on HS at $ 2 , missed it but thanks . I'm going to follow it though its now above $ 5 .



To: ChinuSFO who wrote (215)5/16/1999 3:39:00 PM
From: J R KARY  Respond to of 222
 
Rebounded to 1 7/8ths , steady buying since 5/5/99 Annual Meeting

Might be a technical recovery from (over) selling and/or investment advisors who attended SGD's 5/5/99 AGM are recommending it .

Buyers before SGD's 5/5/99 proxy approval of $1.68 options realized that its price would rise and are not selling .

The year will turn out better than forecasted . SGD has conservative management and wants to guide investors properly but with with caution .

SGD's 3 new skin care products are paid for and will add to '99's 2nd half revenues . Their existing products , though well known by brand , need to be revitalized with more effective advertising .

SGD's Balance Sheet alone should bring it to $2.50 . Key profit objective is for SGD to increase revenues substantially after '98's drop to $40 mln .

Without the family lawsuit burden , '99 should provide a fair test for SGD's management in their quest to rebuild sales .

Any good sales news should move SGD's share price up .

Jim K.



To: ChinuSFO who wrote (215)5/25/1999 11:21:00 PM
From: J R KARY  Respond to of 222
 
Two new product WebSites in production , worth a look

Both are innovative and encourage on-line ordering:

----
SGD's diabetic product line:

135.145.193.220

Could lead toa skin care break-through !
------

SGD's Belleza Latina beauty care line , in English or Spanish:

135.145.193.220

In English or Spanish - about 85% of the World's languages .
----

Ordering is simple , text content is effective and speedy . Maybe the English/Spanish option will be extended to their other sites .

Jim K.



To: ChinuSFO who wrote (215)6/3/1999 3:39:00 PM
From: J R KARY  Read Replies (1) | Respond to of 222
 
SGD mentioned on CNBC today - new Diabetic skin-care product looks good

SGD's new diabetic skin care line to be a biggie if it gets on the general public's shopping list ; hinted at in SGD's Quarterly report .

On CNBC's "Half-time Report" :
----
" Bob O'Brien and Larry Bauman TR, EPIE, WDFC, SGD, and TAMR

TR. O'Brien reports TR Sold 75M worth of sweets. 25B in market-cap. 33M shares
outstanding w/ 20M in public hands. Trade in a tight range. Have been increasing their
dividends. Relatively low yield. 42 1/16 down 1/15 -.15%

EPIE. Canadian company has been offering 13M. EPIE believes this isn't adequate. 9
up ¼ 2.86%

WDFC. 400M company. Made strategic acquisition of Lava Soap 25 15/16

SGD. Unveiled new line of skin care products for diabetes last April. Trades in
extremely narrow range. In first quarter, lost 8 cents/share better than year
before of 10 cent/share loss. Up 1/8 on no real news. 1 ½ up 1/8


TAMR. Bauman asserts this used to be a very large restaurant. Closed then reopened.
Now looking to open a branch in Time Square and New Jersey. 2nd quarter loss of
20 cents was less than ½ of loss from earlier period. 1 ¼ up 3/32 6.38%
------
biocognizance.com

They (Messers O'Brien & Bauman) have a good track record at finding "comers" .

Let's hope SGD turns out to be a winning pick .

Jim K.